We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > neurological disease

News List

Servier and MiNA Therapeutics ink neurology pact pharmatimes
January 25, 2021
French pharma company Servier has entered into a research partnership with UK biotech MiNA Therapeutics to develop small activating RNA (saRNA) therapies for the treatment of neurological diseases.
Roche partners with Jnana on SLC transporters pharmatimes
July 23, 2020
Roche and Jnana Therapeutics have entered into a collaboration to discover new medicines targeting key regulators of cellular metabolism to treat immune-mediated and neurological diseases.
Biogen and Sangamo to develop neurological disease drugs pharmaceutical-technology
March 03, 2020
Biogen and Sangamo Therapeutics have signed a global licensing agreement for the development of drugs to treat neurological diseases, including Alzheimer’s and Parkinson’s diseases.